Figure 3
Rosuvastatin decreased phospho-p38, cleaved caspase-3 and Bax/Bcl-2 protein expression by Western blotting. Beta-Actin was used as a loading control. NDCM: non-diabetic rats + contrast media, D: diabetic group, DCM: diabetic + contrast media group, DR: diabetic + rosuvastatin group, DRCM: diabetic + rosuvastatin + contrast media group. *P < 0.01 vs NDCM, D, DR and DRCM; +P < 0.05 vs NDCM, D and DR; # P < 0.05 vs D and DR.